
Cannae Boosts its Buyback Following DNB Sale – Buyback Wednesdays
This month, we came across an interesting situation when Dun & Bradstreet (DNB) announced its $7.7 billion sale to Clearlake Capital. Cannae Holdings, which owns
Read MoreThis month, we came across an interesting situation when Dun & Bradstreet (DNB) announced its $7.7 billion sale to Clearlake Capital. Cannae Holdings, which owns
Read MoreI am embarrassed to say that I have never downloaded the Lyft app. Despite all the complaints about Uber and friends claiming Lyft is cheaper
Read MoreThere were so many notable stock buyback announcements since the start of 2025 that it became difficult to pick just one for our monthly Buyback
Read MoreSince we last covered the “eatertainment chain” Dave & Buster’s in a Buyback Wednesdays article in April 2023, a lot has changed at the company,
Read MoreAmidst a flurry of earnings reports this month, one company caught my attention with a stock chart full of drama — sharp spikes and steep
Read MoreMSCI delivered strong results in its latest Q3 2024 report, surpassing both top and bottom-line estimates. The company also approved a $1.5 billion share repurchase
Read MoreWillScot Holdings (WSC), a provider of turnkey space solutions, recently caught my attention when the company quickly pivoted to aggressive share repurchases following the termination
Read MoreLast month, Aptiv PLC (APTV) announced a major $5 billion buyback, accounting for over one-fourth of its market cap at the time of announcement. The
Read MoreLast month after we published a C-suite transitions article about the broadcasting company TEGNA (TGNA), I got a chance to discuss a smaller competitor Entravision
Read MoreDiscovering a Financial Unicorn: A Debt-Free Acquisition Master! Companies that embark on a roll-up strategy by acquiring several companies often end up with a highly
Read MoreThe two most important things that sprout in of my mind when I think of Sprouts Farmers Market (SFM), a specialty grocery store focused on
Read MoreRoivant Sciences Ltd. (ROIV): $10.9 Market Cap: $8.78B EV: $2.61B Roivant Sciences (ROIV) stands out in the pharmaceutical industry for two key reasons: its unique
Read More